- Home
- HXL vs RNA Comparison
HXL vs RNA Comparison
Compare HXL & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HXL | RNA |
|---|---|---|
| Founded | 1946 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | HXL | RNA |
|---|---|---|
| Price | $76.22 | $72.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 20 |
| Target Price | ★ $72.88 | $69.26 |
| AVG Volume (30 Days) | 1.2M | ★ 2.3M |
| Earning Date | 01-21-2026 | 11-10-2025 |
| Dividend Yield | ★ 0.89% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.84 | N/A |
| Revenue | ★ $1,876,400,000.00 | $20,868,000.00 |
| Revenue This Year | $0.16 | $57.30 |
| Revenue Next Year | $10.23 | $28.41 |
| P/E Ratio | $90.30 | ★ N/A |
| Revenue Growth | N/A | ★ 106.27 |
| 52 Week Low | $45.28 | $21.51 |
| 52 Week High | $79.20 | $72.61 |
Technical Indicators
Market Signals| Indicator | HXL | RNA |
|---|---|---|
| Relative Strength Index (RSI) | 59.01 | 72.68 |
| Support Level | $72.17 | $71.99 |
| Resistance Level | $77.00 | $72.30 |
| Average True Range (ATR) | 1.66 | 0.28 |
| MACD | -0.05 | -0.36 |
| Stochastic Oscillator | 58.31 | 67.13 |
Price Performance
Historical ComparisonAbout HXL Hexcel Corporation
Founded in 1948, Hexcel designs and manufactures a range of highly engineered composite fibers, fabrics, resins, and structures for use in the commercial aerospace, defense, and high-performance automotive markets. These are lighter than metal and perform under rigorous conditions in aircraft frames, wings, engines, and other components and subassemblies. The company's name derives from the six-sided honeycomb structures that lend many of its products their light weight and rigidity. Hexcel's biggest customers are Airbus (40% of 2024 sales) and Boeing (15% of 2024 sales; 25% before the pandemic) and their respective subcontractors.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.